Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05611749 · ClinicalTrials.gov registry record · Phase 2
Duloxetine Impact on Postoperative Pain Control and Outcomes
A Phase 2 study, sponsored by Scripps Health.
- Terminated
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT05611749 is a Phase 2 study that was terminated before completion, run by Scripps Health. The registered enrollment target is 17 participants.
The verdict
NCT05611749, a Phase 2 study, was terminated before completion, sponsored by Scripps Health.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
1. Evaluate differences between patients taking Duloxetine or placebo following lateral lumbar interbody fusion for postoperative narcotic consumption. 2. Evaluate differences between patients taking Duloxetine or placebo following lateral lumbar interbody fusion for postoperative pain, function, and quality of life. 3. Evaluate the correlation between preoperative screening tests (measuring pain centralization, anxiety, depression, and overall function) and patients' response to treatment (reduction in pain, anxiety, or depression and improvement in function).
Interventions
- OTHER Placebo
- DRUG Duloxetine 60 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-05-30 |
| Est. Completion | 2024-03-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05611749
The ClinicalTrials.gov registry entry for NCT05611749 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Health, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05611749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05611749 about?
NCT05611749 is a clinical study titled "Duloxetine Impact on Postoperative Pain Control and Outcomes". 1. Evaluate differences between patients taking Duloxetine or placebo following lateral lumbar interbody fusion for postoperative narcotic consumption. 2. Evaluate differences between patients taking Duloxetine or placebo following lateral lumbar interbody fusion for postoperative pain, function, an...
What is the current status of trial NCT05611749?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2023-05-30. Estimated completion is 2024-03-25.
What interventions are being tested in trial NCT05611749?
The interventions under investigation include: Placebo (OTHER), Duloxetine 60 MG (DRUG).
Who is sponsoring clinical trial NCT05611749?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.